Kotronen A - Search Results

1

Effect of liver fat on insulin clearance.

Kotronen A, Vehkavaara S, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Kotronen A, et al. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1709-15. doi: 10.1152/ajpendo.00444.2007. Epub 2007 Sep 25. Am J Physiol Endocrinol Metab. 2007. PMID: 17895288 Free article. Clinical Trial.

2

Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome.

Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Kotronen A, et al. Diabetologia. 2008 Jan;51(1):130-8. doi: 10.1007/s00125-007-0867-x. Epub 2007 Nov 16. Diabetologia. 2008. PMID: 18008059

3

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans.

Kotronen A, Johansson LE, Johansson LM, Roos C, Westerbacka J, Hamsten A, Bergholm R, Arkkila P, Arola J, Kiviluoto T, Fisher RM, Ehrenborg E, Orho-Melander M, Ridderstråle M, Groop L, Yki-Järvinen H. Kotronen A, et al. Diabetologia. 2009 Jun;52(6):1056-60. doi: 10.1007/s00125-009-1285-z. Epub 2009 Feb 18. Diabetologia. 2009. PMID: 19224197 Free article.

4

Liver fat in the metabolic syndrome.

Kotronen A, Westerbacka J, Bergholm R, Pietiläinen KH, Yki-Järvinen H. Kotronen A, et al. J Clin Endocrinol Metab. 2007 Sep;92(9):3490-7. doi: 10.1210/jc.2007-0482. Epub 2007 Jun 26. J Clin Endocrinol Metab. 2007. PMID: 17595248

5

Fatty liver: a novel component of the metabolic syndrome.

Kotronen A, Yki-Järvinen H. Kotronen A, et al. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. doi: 10.1161/ATVBAHA.107.147538. Epub 2007 Aug 9. Arterioscler Thromb Vasc Biol. 2008. PMID: 17690317 Review.

6

Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.

Kotronen A, Juurinen L, Hakkarainen A, Westerbacka J, Cornér A, Bergholm R, Yki-Järvinen H. Kotronen A, et al. Diabetes Care. 2008 Jan;31(1):165-9. doi: 10.2337/dc07-1463. Epub 2007 Oct 12. Diabetes Care. 2008. PMID: 17934148

7

Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses.

Juurinen L, Kotronen A, Granér M, Yki-Järvinen H. Juurinen L, et al. Among authors: kotronen a. J Clin Endocrinol Metab. 2008 Jan;93(1):118-24. doi: 10.1210/jc.2007-1825. Epub 2007 Oct 23. J Clin Endocrinol Metab. 2008. PMID: 17956948

8

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H. Kotronen A, et al. Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21. Gastroenterology. 2008. PMID: 18474251

9

Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.

Kotronen A, Lewitt M, Hall K, Brismar K, Yki-Järvinen H. Kotronen A, et al. J Clin Endocrinol Metab. 2008 Dec;93(12):4867-72. doi: 10.1210/jc.2008-1245. Epub 2008 Sep 16. J Clin Endocrinol Metab. 2008. PMID: 18796514

10

Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts.

Kotronen A, Yki-Järvinen H, Aminoff A, Bergholm R, Pietiläinen KH, Westerbacka J, Talmud PJ, Humphries SE, Hamsten A, Isomaa B, Groop L, Orho-Melander M, Ehrenborg E, Fisher RM. Kotronen A, et al. Eur J Endocrinol. 2009 Apr;160(4):593-602. doi: 10.1530/EJE-08-0900. Epub 2009 Feb 10. Eur J Endocrinol. 2009. PMID: 19208777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page